Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Diabetes oral medication initiation and intensification: patient views compared with current treatment guidelines.

Grant RW, Pabon-Nau L, Ross KM, Youatt EJ, Pandiscio JC, Park ER.

Diabetes Educ. 2011 Jan-Feb;37(1):78-84. doi: 10.1177/0145721710388427. Epub 2010 Nov 29.

2.

Impact of time to treatment intensification on glycemic goal attainment among patients with type 2 diabetes failing metformin monotherapy.

Rajpathak SN, Rajgopalan S, Engel SS.

J Diabetes Complications. 2014 Nov-Dec;28(6):831-5. doi: 10.1016/j.jdiacomp.2014.06.004. Epub 2014 Jun 19.

PMID:
25104238
3.

Use of an Electronic Medical Record (EMR) to Identify Glycemic Intensification Strategies in Type 2 Diabetes.

Korytkowski MT, Brooks M, Lombardero M, DeAlmeida D, Kanter J, Magaji V, Orchard T, Siminerio L.

J Diabetes Sci Technol. 2015 May;9(3):593-601. doi: 10.1177/1932296814564183. Epub 2014 Dec 18.

4.

Intensification of antihyperglycemic therapy among patients with incident diabetes: a Surveillance Prevention and Management of Diabetes Mellitus (SUPREME-DM) study.

Raebel MA, Ellis JL, Schroeder EB, Xu S, O'Connor PJ, Segal JB, Butler MG, Schmittdiel JA, Kirchner HL, Goodrich GK, Lawrence JM, Nichols GA, Newton KM, Pathak RD, Steiner JF.

Pharmacoepidemiol Drug Saf. 2014 Jul;23(7):699-710. doi: 10.1002/pds.3610. Epub 2014 Mar 18.

PMID:
24639086
5.

Factors associated with intensification of oral diabetes medications in primary care provider-patient dyads: a cohort study.

Bolen SD, Bricker E, Samuels TA, Yeh HC, Marinopoulos SS, McGuire M, Abuid M, Brancati FL.

Diabetes Care. 2009 Jan;32(1):25-31. doi: 10.2337/dc08-1297. Epub 2008 Oct 17. Erratum in: Diabetes Care. 2009 Jun;32(6):1134.

6.

Relationship between patient medication adherence and subsequent clinical inertia in type 2 diabetes glycemic management.

Grant R, Adams AS, Trinacty CM, Zhang F, Kleinman K, Soumerai SB, Meigs JB, Ross-Degnan D.

Diabetes Care. 2007 Apr;30(4):807-12. Epub 2007 Jan 26.

PMID:
17259469
8.

Trends in insulin initiation and treatment intensification among patients with type 2 diabetes.

Patrick AR, Fischer MA, Choudhry NK, Shrank WH, Seeger JD, Liu J, Avorn J, Polinski JM.

J Gen Intern Med. 2014 Feb;29(2):320-7. doi: 10.1007/s11606-013-2643-6. Epub 2013 Oct 8.

9.

Diabetes and poor disease control: is comorbid depression associated with poor medication adherence or lack of treatment intensification?

Katon W, Russo J, Lin EH, Heckbert SR, Karter AJ, Williams LH, Ciechanowski P, Ludman E, Von Korff M.

Psychosom Med. 2009 Nov;71(9):965-72. doi: 10.1097/PSY.0b013e3181bd8f55. Epub 2009 Oct 15.

10.

Primary language, income and the intensification of anti-glycemic medications in managed care: the (TRIAD) study.

Duru OK, Bilik D, McEwen LN, Brown AF, Karter AJ, Curb JD, Marrero DG, Lu SE, Rodriguez M, Mangione CM.

J Gen Intern Med. 2011 May;26(5):505-11. doi: 10.1007/s11606-010-1588-2. Epub 2010 Dec 21.

11.

Getting under the skin of clinical inertia in insulin initiation: the Translating Research Into Action for Diabetes (TRIAD) Insulin Starts Project.

Ratanawongsa N, Crosson JC, Schillinger D, Karter AJ, Saha CK, Marrero DG.

Diabetes Educ. 2012 Jan-Feb;38(1):94-100. doi: 10.1177/0145721711432649. Epub 2012 Jan 5.

12.

Diabetes management in the real world and the impact of adherence to guideline recommendations.

Lian J, Liang Y.

Curr Med Res Opin. 2014 Nov;30(11):2233-40. doi: 10.1185/03007995.2014.952716. Epub 2014 Aug 29.

PMID:
25105305
13.

Reasons for non-intensification of treatment in people with type 2 diabetes receiving oral monotherapy: Outcomes from the prospective DIAttitude study.

Balkau B, Halimi S, Blickle JF, Vergès B, Avignon A, Attali C, Chartier I, Amelineau E.

Ann Endocrinol (Paris). 2016 Dec;77(6):649-657. doi: 10.1016/j.ando.2016.03.001. Epub 2016 Sep 16.

PMID:
27646493
14.

Intensification of medication and glycaemic control among patients with type 2 diabetes - the ADVANCE trial.

van Dieren S, Kengne AP, Chalmers J, Beulens JW, Davis TM, Fulcher G, Heller SR, Patel A, Colagiuri S, Hamet P, Mancia G, Marre M, Neal B, Williams B, Peelen LM, van der Schouw YT, Woodward M, Zoungas S.

Diabetes Obes Metab. 2014 May;16(5):426-32. doi: 10.1111/dom.12238. Epub 2013 Dec 16.

PMID:
24251579
15.

Intensification of insulin therapy in patients with type 2 diabetes mellitus: an algorithm for basal-bolus therapy.

Abrahamson MJ, Peters A.

Ann Med. 2012 Dec;44(8):836-46. doi: 10.3109/07853890.2012.699715. Epub 2012 Jul 23. Review.

16.

Predictors and impact of intensification of antihyperglycemic therapy in type 2 diabetes: translating research into action for diabetes (TRIAD).

McEwen LN, Bilik D, Johnson SL, Halter JB, Karter AJ, Mangione CM, Subramanian U, Waitzfelder B, Crosson JC, Herman WH.

Diabetes Care. 2009 Jun;32(6):971-6. doi: 10.2337/dc08-1911. Epub 2009 Feb 19.

18.

Diabetes knowledge, medication adherence and glycemic control among patients with type 2 diabetes.

Al-Qazaz HKh, Sulaiman SA, Hassali MA, Shafie AA, Sundram S, Al-Nuri R, Saleem F.

Int J Clin Pharm. 2011 Dec;33(6):1028-35. doi: 10.1007/s11096-011-9582-2. Epub 2011 Nov 15.

PMID:
22083724
19.

Glycemic targets and medication limitations for type 2 diabetes mellitus in the older adult.

Thompson AM, Linnebur SA, Vande Griend JP, Saseen JJ.

Consult Pharm. 2014 Feb;29(2):110-23. doi: 10.4140/TCP.n.2014.110. Review.

PMID:
24513421
20.

Medication adherence and racial differences in A1C control.

Adams AS, Trinacty CM, Zhang F, Kleinman K, Grant RW, Meigs JB, Soumerai SB, Ross-Degnan D.

Diabetes Care. 2008 May;31(5):916-21. doi: 10.2337/dc07-1924. Epub 2008 Jan 30.

Supplemental Content

Support Center